Prevalence of HBsAg-positive and anti-HCV-positive thalassemia patients
| Reference . | Geographic area . | Screened subjects, no. . | HBsAg+, % . | Anti-HCV+, % . |
|---|---|---|---|---|
| 13 | Iran | 732 | 1.5 | 19.3 |
| 14 | Turkey | 399 | 0.8 | 4.4 |
| 15 | Thailand | 104 | 2 | 21.2 |
| 16 | Lebanon | 395 | 0.3 | 14 |
| 17 | India | 104 | 3.8 | 21 |
| 18 | Malaysia | 85 | 2.4 | 22.4 |
| 19 | Malaysia | 72 | 1 | 13 |
| 20 | India | 70 | 5.7 | ND |
| 21 | Iraq | 559 | ND | 67.3 |
| 22 | Pakistan | 35 | ND | 60 |
| 23 | Italy | 1481 | ND | 85.2 |
| 24 | Bahrain | 242 | ND | 20.5 |
| 25 | Brazil | 32 | ND | 46.8 |
| 26 | Hong Kong | 99 | ND | 34 |
| 27 | UK | 73 | ND | 23.3 |
| Reference . | Geographic area . | Screened subjects, no. . | HBsAg+, % . | Anti-HCV+, % . |
|---|---|---|---|---|
| 13 | Iran | 732 | 1.5 | 19.3 |
| 14 | Turkey | 399 | 0.8 | 4.4 |
| 15 | Thailand | 104 | 2 | 21.2 |
| 16 | Lebanon | 395 | 0.3 | 14 |
| 17 | India | 104 | 3.8 | 21 |
| 18 | Malaysia | 85 | 2.4 | 22.4 |
| 19 | Malaysia | 72 | 1 | 13 |
| 20 | India | 70 | 5.7 | ND |
| 21 | Iraq | 559 | ND | 67.3 |
| 22 | Pakistan | 35 | ND | 60 |
| 23 | Italy | 1481 | ND | 85.2 |
| 24 | Bahrain | 242 | ND | 20.5 |
| 25 | Brazil | 32 | ND | 46.8 |
| 26 | Hong Kong | 99 | ND | 34 |
| 27 | UK | 73 | ND | 23.3 |
ND indicates not done.